| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ABCA2 PDE4A UBE4B UBE3B UBR4 NAGLU SREBF1 IRAK1 LARS2 ZZEF1 STK11IP TIAM2 MAP3K5 LATS2 RAB43 OSBPL5 SEC16A TANC1 KIFC3 SPEN DHX34 | 1.18e-08 | 1105 | 149 | 21 | 35748872 |
| Pubmed | TTC28 MYO19 UBE3B RALGAPB SREBF1 ANKRD50 ZZEF1 RFWD3 CDC45 GLB1 TANC1 PLCH1 HSD17B4 DHX34 GARRE1 | 1.47e-07 | 650 | 149 | 15 | 38777146 | |
| Pubmed | ABCA2 ANK3 TTC28 MYO5A UBE4B UBR4 SYNC RIPK4 TRIM33 CRNKL1 DGLUCY TTC7B ARHGEF10 ARID5B MACF1 KIFC3 HSD17B4 USPL1 DNAJA1 TARBP1 DOP1B | 1.51e-07 | 1285 | 149 | 21 | 35914814 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | TBC1D30 POLA1 MYO19 UBR4 NAGLU SYNC ZZEF1 IGSF10 RANBP3L TLR3 ARID5B ANKRD18A CEP295 DNAJA1 DOP1B | 7.06e-07 | 736 | 149 | 15 | 29676528 |
| Pubmed | 3.86e-06 | 282 | 149 | 9 | 23667531 | ||
| Pubmed | 6.17e-06 | 225 | 149 | 8 | 12168954 | ||
| Pubmed | TTC28 MCC IRAK1 ZZEF1 TTC7A TRIM33 SLIT2 PBRM1 SEC16A MACF1 CEP295 TANC1 DNAJA1 DHX34 GARRE1 TENT2 UNC80 | 6.45e-06 | 1116 | 149 | 17 | 31753913 | |
| Pubmed | ANK3 RALGAPB FAM171B ANKRD50 TTC7B GLB1 ARHGEF10 SEC16A MACF1 PLCH1 | 1.49e-05 | 421 | 149 | 10 | 36976175 | |
| Pubmed | DLGAP2 PDE4A ANK3 MYO5A UBR4 MCC GRIA2 SPECC1L MAP3K5 PBRM1 FARP1 SEC16A MACF1 CDC73 DNAJA1 | 1.80e-05 | 963 | 149 | 15 | 28671696 | |
| Pubmed | ANK3 FBXW12 MARS1 CEP162 FAM171B ANKRD50 TIAM2 ZNF750 HAUS1 FARP1 ARID5B SEC16A MACF1 CEP295 HSD3B1 ZNF445 | 1.80e-05 | 1084 | 149 | 16 | 11544199 | |
| Pubmed | A locus determining beta-galactosidase activity in the mouse. | 1.82e-05 | 2 | 149 | 2 | 4830244 | |
| Pubmed | Association between beta-galactosidase activities and coat color in mice. | 1.82e-05 | 2 | 149 | 2 | 4782668 | |
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 39052101 | ||
| Pubmed | 1.82e-05 | 2 | 149 | 2 | 31372216 | ||
| Pubmed | 1.91e-05 | 263 | 149 | 8 | 34702444 | ||
| Pubmed | 2.39e-05 | 197 | 149 | 7 | 36604605 | ||
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 2.76e-05 | 361 | 149 | 9 | 26167880 | |
| Pubmed | ANK3 MYO5A CEP162 DUSP9 RALGAPB NAGLU FAM171B TTC7B HAUS1 FARP1 NUP210 SEC16A TANC1 HSD17B4 DNAJA1 | 4.79e-05 | 1049 | 149 | 15 | 27880917 | |
| Pubmed | CircLRFN5 inhibits the progression of glioblastoma via PRRX2/GCH1 mediated ferroptosis. | 5.45e-05 | 3 | 149 | 2 | 36266731 | |
| Pubmed | KNK437 restricts the growth and metastasis of colorectal cancer via targeting DNAJA1/CDC45 axis. | 5.45e-05 | 3 | 149 | 2 | 31477839 | |
| Pubmed | 5.45e-05 | 3 | 149 | 2 | 478292 | ||
| Pubmed | 5.45e-05 | 3 | 149 | 2 | 34731623 | ||
| Pubmed | MyD88 adaptor-like is not essential for TLR2 signaling and inhibits signaling by TLR3. | 5.45e-05 | 3 | 149 | 2 | 19717524 | |
| Pubmed | The KBTBD6/7-DRD2 axis regulates pituitary adenoma sensitivity to dopamine agonist treatment. | 5.45e-05 | 3 | 149 | 2 | 32572597 | |
| Pubmed | 5.45e-05 | 3 | 149 | 2 | 31222667 | ||
| Pubmed | Large tumor suppressor 2, LATS2, activates JNK in a kinase-independent mechanism through ASK1. | 5.45e-05 | 3 | 149 | 2 | 30496488 | |
| Pubmed | Genetic determination of the beta-galactosidase developmental program in mouse liver. | 5.45e-05 | 3 | 149 | 2 | 1009575 | |
| Pubmed | 5.45e-05 | 3 | 149 | 2 | 10518787 | ||
| Pubmed | Linkage analysis of the murine Hyal-1 locus on chromosome 9. | 5.45e-05 | 3 | 149 | 2 | 2022949 | |
| Pubmed | 5.45e-05 | 3 | 149 | 2 | 828052 | ||
| Pubmed | Tumoural activation of TLR3-SLIT2 axis in endothelium drives metastasis. | 5.45e-05 | 3 | 149 | 2 | 32999457 | |
| Pubmed | 5.45e-05 | 3 | 149 | 2 | 18281655 | ||
| Pubmed | 6.96e-05 | 407 | 149 | 9 | 12693553 | ||
| Pubmed | Toll-like receptor signaling pathway variants and prostate cancer mortality. | 7.10e-05 | 19 | 149 | 3 | 19505919 | |
| Pubmed | 8.05e-05 | 102 | 149 | 5 | 10231032 | ||
| Pubmed | TTC28 CWC15 ICE2 MCC GLB1 ARHGEF10 SEC16A CEP295 PRR14L TANC1 PLCH1 DNAJA1 | 8.05e-05 | 733 | 149 | 12 | 34672954 | |
| Pubmed | 8.82e-05 | 104 | 149 | 5 | 9205841 | ||
| Pubmed | ANK3 TTC28 MYO5A MYO19 UBR4 SPECC1L GLB1 CSTF1 MACF1 CDC73 XPO7 | 9.67e-05 | 634 | 149 | 11 | 34591612 | |
| Pubmed | ABCA2 CEP162 ANKRD50 ZZEF1 TIAM2 CNOT6 TRIM33 OSBPL5 DHX34 GARRE1 | 1.01e-04 | 529 | 149 | 10 | 14621295 | |
| Pubmed | COG7 MARS1 POLA1 UBR4 IRAK1 TRIM33 CRNKL1 NUP210 CDC73 HSD17B4 DNAJA1 | 1.02e-04 | 638 | 149 | 11 | 33239621 | |
| Pubmed | 1.09e-04 | 4 | 149 | 2 | 1329656 | ||
| Pubmed | 1.09e-04 | 4 | 149 | 2 | 11013081 | ||
| Pubmed | 1.09e-04 | 4 | 149 | 2 | 20061547 | ||
| Pubmed | 1.09e-04 | 4 | 149 | 2 | 21037240 | ||
| Pubmed | 1.09e-04 | 4 | 149 | 2 | 11747467 | ||
| Pubmed | 1.09e-04 | 4 | 149 | 2 | 9314494 | ||
| Pubmed | Structural basis of myosin V Rab GTPase-dependent cargo recognition. | 1.09e-04 | 4 | 149 | 2 | 24248336 | |
| Pubmed | Linkage analysis of the Gi alpha 2 gene on mouse chromosome 9. | 1.09e-04 | 4 | 149 | 2 | 1421769 | |
| Pubmed | 1.09e-04 | 4 | 149 | 2 | 26970254 | ||
| Pubmed | 1.09e-04 | 4 | 149 | 2 | 1871601 | ||
| Pubmed | TLR3-mediated IFN-β gene induction is negatively regulated by the TLR adaptor MyD88 adaptor-like. | 1.09e-04 | 4 | 149 | 2 | 20957750 | |
| Pubmed | 1.09e-04 | 4 | 149 | 2 | 14508709 | ||
| Pubmed | 1.10e-04 | 251 | 149 | 7 | 27507650 | ||
| Pubmed | 1.15e-04 | 58 | 149 | 4 | 31067491 | ||
| Pubmed | MYO5A POLA1 UBR4 CRNKL1 PBRM1 NUP210 SEC16A MACF1 DNAJA1 SPEN XPO7 | 1.25e-04 | 653 | 149 | 11 | 22586326 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | MYO5A MARS1 IRAK1 SPECC1L SLIT2 CRNKL1 PBRM1 NUP210 SEC16A MACF1 HSD17B4 DNAJA1 SPEN XPO7 | 1.38e-04 | 1024 | 149 | 14 | 24711643 |
| Pubmed | Interaction of amyloid precursor protein with contactins and NgCAM in the retinotectal system. | 1.81e-04 | 5 | 149 | 2 | 18272596 | |
| Pubmed | 1.81e-04 | 5 | 149 | 2 | 23390603 | ||
| Pubmed | 1.81e-04 | 5 | 149 | 2 | 20400509 | ||
| Pubmed | A novel IRAK1-IKKε signaling axis limits the activation of TAK1-IKKβ downstream of TLR3. | 1.81e-04 | 5 | 149 | 2 | 23396947 | |
| Pubmed | 1.81e-04 | 5 | 149 | 2 | 27539848 | ||
| Pubmed | 1.81e-04 | 5 | 149 | 2 | 17878161 | ||
| Pubmed | 1.81e-04 | 5 | 149 | 2 | 38942763 | ||
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 2.20e-04 | 281 | 149 | 7 | 28706196 | |
| Pubmed | 2.30e-04 | 283 | 149 | 7 | 21903422 | ||
| Pubmed | 2.70e-04 | 6 | 149 | 2 | 18295350 | ||
| Pubmed | 2.70e-04 | 6 | 149 | 2 | 25254289 | ||
| Pubmed | 2.70e-04 | 6 | 149 | 2 | 12719437 | ||
| Pubmed | The role of hyaluronan degradation products as innate alloimmune agonists. | 2.70e-04 | 6 | 149 | 2 | 17049055 | |
| Pubmed | 3.17e-04 | 31 | 149 | 3 | 36362374 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TTC28 PDGFRA CEP162 RALGAPB FSIP2 ARHGEF10 SEC16A MACF1 TANC1 PLCH1 GARRE1 DOP1B | 3.53e-04 | 861 | 149 | 12 | 36931259 |
| Pubmed | Sequential control of Toll-like receptor-dependent responses by IRAK1 and IRAK2. | 3.78e-04 | 7 | 149 | 2 | 18438411 | |
| Pubmed | 3.78e-04 | 7 | 149 | 2 | 19378012 | ||
| Pubmed | PtdIns4P synthesis by PI4KIIIα at the plasma membrane and its impact on plasma membrane identity. | 3.78e-04 | 7 | 149 | 2 | 23229899 | |
| Pubmed | 3.78e-04 | 7 | 149 | 2 | 33990333 | ||
| Pubmed | 3.78e-04 | 7 | 149 | 2 | 23417039 | ||
| Pubmed | MAPPIT analysis of early Toll-like receptor signalling events. | 3.78e-04 | 7 | 149 | 2 | 18221795 | |
| Pubmed | 3.99e-04 | 515 | 149 | 9 | 31617661 | ||
| Pubmed | 4.47e-04 | 226 | 149 | 6 | 31452512 | ||
| Pubmed | 5.02e-04 | 8 | 149 | 2 | 12724322 | ||
| Pubmed | Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. | 5.02e-04 | 8 | 149 | 2 | 11544529 | |
| Pubmed | TLR11 activation of dendritic cells by a protozoan profilin-like protein. | 5.02e-04 | 8 | 149 | 2 | 15860593 | |
| Pubmed | Common genetic variants on 1p13.2 associate with risk of autism. | 5.02e-04 | 8 | 149 | 2 | 24189344 | |
| Pubmed | 5.02e-04 | 8 | 149 | 2 | 37315734 | ||
| Pubmed | 5.36e-04 | 234 | 149 | 6 | 36243803 | ||
| Pubmed | ANK3 TTC28 CEP162 SPECC1L FAM171B ANKRD50 TRIM33 LIPE SEC16A SPEN XPO7 | 5.48e-04 | 777 | 149 | 11 | 35844135 | |
| Pubmed | 5.95e-04 | 89 | 149 | 4 | 23891004 | ||
| Pubmed | Characterization of lipid-linked oligosaccharide accumulation in mouse models of Batten disease. | 6.44e-04 | 9 | 149 | 2 | 15647513 | |
| Pubmed | 6.44e-04 | 9 | 149 | 2 | 16210631 | ||
| Pubmed | Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. | 6.44e-04 | 9 | 149 | 2 | 12855817 | |
| Pubmed | 7.09e-04 | 446 | 149 | 8 | 24255178 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYO5A UBE4B MARS1 POLA1 MYO19 UBR4 CDC45 CRNKL1 SEC16A CSTF1 MACF1 PRR14L TANC1 DNAJA1 DHX34 | 7.33e-04 | 1353 | 149 | 15 | 29467282 |
| Pubmed | 7.61e-04 | 95 | 149 | 4 | 29490077 | ||
| Pubmed | Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. | 8.02e-04 | 10 | 149 | 2 | 11923871 | |
| Pubmed | 8.02e-04 | 10 | 149 | 2 | 31852751 | ||
| Pubmed | 8.02e-04 | 10 | 149 | 2 | 25390645 | ||
| Pubmed | 8.02e-04 | 10 | 149 | 2 | 24084649 | ||
| Pubmed | 9.57e-04 | 101 | 149 | 4 | 26949739 | ||
| Pubmed | Trim33 is required for appropriate development of pre-cardiogenic mesoderm. | 9.78e-04 | 11 | 149 | 2 | 30940539 | |
| Pubmed | 9.78e-04 | 11 | 149 | 2 | 24391503 | ||
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 4.65e-04 | 115 | 101 | 5 | 769 | |
| Coexpression | GSE7460_WT_VS_FOXP3_HET_ACT_TCONV_UP | 1.74e-05 | 199 | 147 | 8 | M5709 | |
| Coexpression | GSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_DN | 1.74e-05 | 199 | 147 | 8 | M6964 | |
| Coexpression | GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN | 1.74e-05 | 199 | 147 | 8 | M6987 | |
| Coexpression | GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_BCL6_HET_UP | 1.80e-05 | 200 | 147 | 8 | M9354 | |
| Coexpression | GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MACROPHAGE_DN | 1.80e-05 | 200 | 147 | 8 | M7750 | |
| Coexpression | CARRILLOREIXACH_MRS3_VS_LOWER_RISK_HEPATOBLASTOMA_DN | 4.70e-05 | 168 | 147 | 7 | M45039 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 4.76e-06 | 198 | 149 | 7 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.08e-06 | 200 | 149 | 7 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9|TCGA-Bladder / Sample_Type by Project: Shred V9 | 2.42e-05 | 171 | 149 | 6 | adbcfa4bf6bc1c604535a24435924cdb091e2dd7 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-05 | 180 | 149 | 6 | dd1b10c7f5a0fbc63163844ca1882884a24a84d3 | |
| ToppCell | droplet-Liver-LIVER_HEP|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.22e-05 | 180 | 149 | 6 | 423454e3390080ae03bb3cbb267255ebfe4df080 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.33e-05 | 181 | 149 | 6 | af92b8b7f455210dab502ef6964f3a0162180759 | |
| ToppCell | IPF-Epithelial-Basal|World / Disease state, Lineage and Cell class | 4.62e-05 | 192 | 149 | 6 | 9b91e0b162e6f3ce86dd15cc33c2e745d069581f | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-05 | 193 | 149 | 6 | d8ccfb780a75bdf9141f41fb29a076958601ebb4 | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-basal_bladder_epithelial_cell_(Krt5+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-05 | 193 | 149 | 6 | 268925bfe85fb94a93a4ff8fe078d692df888140 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.76e-05 | 193 | 149 | 6 | 8084fa0ce61f1f4a728423b6b81df04eaa5af5b6 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.18e-05 | 196 | 149 | 6 | 50aaca81b593ff71790bb75403b2e4c3ab03a6d2 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.33e-05 | 197 | 149 | 6 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.33e-05 | 197 | 149 | 6 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.48e-05 | 198 | 149 | 6 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | COVID-19_Severe-Neu_4|COVID-19_Severe / 5 Neutrophil clusters in COVID-19 patients | 5.48e-05 | 198 | 149 | 6 | bfdddddef9f3f0eb6af013873dec4e06b7c78c58 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.64e-05 | 199 | 149 | 6 | e1849505b92820a219c5a2c35492bdd55579fb48 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.80e-05 | 200 | 149 | 6 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-Neuronal|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 5.80e-05 | 200 | 149 | 6 | 1decf1d2cba5ebfd3e5cd4bcd637db8f193033ce | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.80e-05 | 200 | 149 | 6 | b79628fd1386aa9a3b0e9fa81def0bc100c3c073 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 5.80e-05 | 200 | 149 | 6 | 1276bfa911fddada4235e12e3081baa53164574b | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.80e-05 | 200 | 149 | 6 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.80e-05 | 200 | 149 | 6 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.80e-05 | 200 | 149 | 6 | 50ca6550998e461ef26dd670351060bd940765a8 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 5.80e-05 | 200 | 149 | 6 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.80e-05 | 200 | 149 | 6 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.80e-05 | 200 | 149 | 6 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.80e-05 | 200 | 149 | 6 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.80e-05 | 200 | 149 | 6 | 310cd53db1c137f6af74e6ae682221d7ac27310c | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_submucosal-gland|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.80e-05 | 200 | 149 | 6 | 0eb9ad8c0373bcc62029ec21c590ed03aaacd039 | |
| ToppCell | Macroglial-Polydendrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 5.80e-05 | 200 | 149 | 6 | 961858738ce35db8760c8c2e136f8369bc444ccf | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.80e-05 | 200 | 149 | 6 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | COVID-19_Severe-Neu_3|COVID-19_Severe / 5 Neutrophil clusters in COVID-19 patients | 5.88e-05 | 123 | 149 | 5 | 4c20c025b6f19f075a13282288fc537e6e186217 | |
| ToppCell | COVID-19_Severe-Neu_3|World / 5 Neutrophil clusters in COVID-19 patients | 6.11e-05 | 124 | 149 | 5 | 54b42ffb161eece4ae308782e43a0e0dc360281e | |
| ToppCell | Control-PLT_5|World / Disease Group and Platelet Clusters | 6.59e-05 | 126 | 149 | 5 | 4ba753c4e83eb1d41964edfa22135e047f06c481 | |
| Disease | urate measurement, bone density | DLGAP2 TTC28 UBE4B NPAS3 MCC RIPK4 TIAM2 FSIP2 LATS2 GPR149 ARID5B SEC16A DNAH9 | 1.07e-05 | 619 | 143 | 13 | EFO_0003923, EFO_0004531 |
| Disease | Perrault syndrome (is_implicated_in) | 2.31e-04 | 5 | 143 | 2 | DOID:0050857 (is_implicated_in) | |
| Disease | depressive symptom measurement | 2.43e-04 | 426 | 143 | 9 | EFO_0007006 | |
| Disease | obsolete_red blood cell distribution width | TTC28 MYO19 UBE3B R3HDM2 ITGAD ADGRL4 TRIM33 STAC2 PBRM1 HAUS1 NFE2 CNTN5 NUP210 GPSM1 GARRE1 CERS4 ACOXL | 2.93e-04 | 1347 | 143 | 17 | EFO_0005192 |
| Disease | Perrault syndrome | 3.45e-04 | 6 | 143 | 2 | cv:C0685838 | |
| Disease | disease of metabolism (is_implicated_in) | 3.45e-04 | 6 | 143 | 2 | DOID:0014667 (is_implicated_in) | |
| Disease | cerebral infarction (implicated_via_orthology) | 3.45e-04 | 6 | 143 | 2 | DOID:3526 (implicated_via_orthology) | |
| Disease | Nonorganic psychosis | 3.58e-04 | 69 | 143 | 4 | C0349204 | |
| Disease | Gonadal dysgenesis XX type deafness | 4.82e-04 | 7 | 143 | 2 | C0685838 | |
| Disease | Situs ambiguous | 8.21e-04 | 9 | 143 | 2 | C1167664 | |
| Disease | telomere length | 8.64e-04 | 313 | 143 | 7 | EFO_0004505 | |
| Disease | mean corpuscular hemoglobin concentration | TTC28 GCH1 ADGRL4 TRIM33 HAUS1 NFE2 CNTN5 RAB43 SEC16A MACF1 PARP9 LY75 ACOXL XPO7 | 9.87e-04 | 1105 | 143 | 14 | EFO_0004528 |
| Disease | Situs Inversus | 1.25e-03 | 11 | 143 | 2 | C0037221 | |
| Disease | Psychotic Disorders | 1.50e-03 | 101 | 143 | 4 | C0033975 | |
| Disease | Fetal Alcohol Spectrum Disorders | 1.76e-03 | 13 | 143 | 2 | C2985290 | |
| Disease | mean reticulocyte volume | IRAK1 SPECC1L CNOT6 TTC7A TRIM33 NFE2 CNTN5 LY75 CERS4 ACOXL XPO7 | 1.82e-03 | 799 | 143 | 11 | EFO_0010701 |
| Disease | Bipolar Disorder | 2.34e-03 | 477 | 143 | 8 | C0005586 | |
| Disease | Situs ambiguus | 2.35e-03 | 15 | 143 | 2 | C0266642 | |
| Disease | gout, hyperuricemia | 2.68e-03 | 16 | 143 | 2 | EFO_0004274, EFO_0009104 | |
| Disease | phosphatidylcholine measurement | 2.68e-03 | 284 | 143 | 6 | EFO_0010226 | |
| Disease | Fetal Alcohol Syndrome | 3.02e-03 | 17 | 143 | 2 | C0015923 | |
| Disease | Cocaine Abuse | 3.45e-03 | 127 | 143 | 4 | C0009171 | |
| Disease | colorectal cancer, inflammatory bowel disease | 3.78e-03 | 19 | 143 | 2 | EFO_0003767, MONDO_0005575 | |
| Disease | Schizophrenia | ANKK1 DLGAP2 PDE4A ANK3 SREBF1 NPAS3 GRIA2 GCH1 LARS2 PBRM1 TLR3 | 3.91e-03 | 883 | 143 | 11 | C0036341 |
| Disease | macrophage inflammatory protein 1b measurement | 4.40e-03 | 136 | 143 | 4 | EFO_0008219 | |
| Disease | gestational age, birth measurement | 4.61e-03 | 21 | 143 | 2 | EFO_0005112, EFO_0006921 | |
| Disease | Cocaine Dependence | 4.75e-03 | 139 | 143 | 4 | C0600427 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LAESSSLLGYKNNTI | 166 | Q9HBW9 | |
| STNALGLLELYRTFE | 286 | Q14032 | |
| NKLLSSGSRYLIRSD | 631 | O15013 | |
| TFSYSANLLRIGSLV | 221 | Q9HA82 | |
| NRILSTAGKYLSDSC | 491 | P83436 | |
| AVYNKGTSLAERLLS | 141 | Q8IVF6 | |
| RKDLLGYLNGEASTS | 91 | Q6P1J9 | |
| DNLNYTLSKEFGLRL | 266 | P14060 | |
| SDSGNYLKRALQLSD | 331 | Q8NFD2 | |
| RLDNSEKLFGYQSLS | 281 | Q69YQ0 | |
| SRGLYNSTDSLDSNK | 656 | Q9P1A6 | |
| NDASRGTLSSYSLVL | 321 | Q6PIY7 | |
| RTLLANAAYSGSLDV | 546 | Q9ULJ7 | |
| GDLSQLSKQYSSRDL | 21 | Q9P013 | |
| LSVTLEDLYNGATRK | 111 | P31689 | |
| SRSLQALVAGLKAYS | 321 | Q9NUZ1 | |
| SAYLSKELASLLRAG | 581 | P54802 | |
| SILSREATLQFAYLG | 181 | O94779 | |
| YLNDIRLSKEAFSSS | 276 | Q9Y2K5 | |
| SLRNEKRGSSYLISA | 646 | Q9HCJ3 | |
| ANGAILAYDITKRSS | 91 | Q86YS6 | |
| SSYLRGLLLSASLDN | 506 | Q6PCD5 | |
| AYNEKSGRITSLSLL | 11 | Q8IXQ6 | |
| DIGVNALLSYKLSSS | 161 | Q9Y5H9 | |
| KLISNATRSLVYDNG | 326 | Q96NI6 | |
| NSEGLTLLDLLSFTY | 786 | P16234 | |
| IKLQTNRDGAASLSY | 1306 | Q8TEM1 | |
| GAFSELSSLRELYLQ | 256 | Q7Z5L7 | |
| KLSSLEYLDLSSNNL | 286 | Q7Z5L7 | |
| LSNLSLVDLGYSSAV | 61 | A6NL26 | |
| SINSDTGILYALRSF | 506 | Q9Y5G7 | |
| LKYIEGLSAESNSIS | 1611 | Q86U86 | |
| YISNLRKQLETLSGD | 186 | Q86Y46 | |
| SRNSLNVDLYELGST | 351 | Q9NRM7 | |
| DAKYSVRTAASLLGL | 326 | Q96H55 | |
| DLKTLSAIYSQLGNA | 61 | Q86YR5 | |
| ILDKSTQADFRLYGS | 221 | Q5MY95 | |
| GSDLKLSYTQSGNSL | 401 | Q9Y3R5 | |
| SSLYDILARGASVNL | 291 | P16278 | |
| KSQLGFLNVTSYSRL | 31 | Q3SXM0 | |
| GQSKSSLELRSYDSN | 3896 | Q5CZC0 | |
| LYDSDRGLSTLQAVL | 151 | P42262 | |
| AFETELAYLSGNRLT | 96 | Q6X9E4 | |
| SRKLTIRASDGLYQD | 1936 | Q9NYQ8 | |
| TSSGVLLLDNYSDRI | 566 | P27815 | |
| LYLGSARDSANLESL | 211 | Q99956 | |
| GADLLSINSAAELTY | 251 | O60449 | |
| NLRYSAKSLFSLVLG | 81 | Q9Y546 | |
| SAALLAQLKSFYDAR | 46 | Q8WVZ9 | |
| YEDGALDSLQLLSSS | 676 | P51617 | |
| QLLSILGFLYSEDSA | 371 | O43934 | |
| GNLYRSILLTSQDKA | 626 | Q3MIN7 | |
| TDSLTSFIRQLNLYG | 131 | A0A1B0GWH4 | |
| LSRSGYSEVNLSKLF | 1441 | P09884 | |
| SSNAQLLLDYCSSKG | 201 | Q9Y251 | |
| LGELKEQYSTSLAQS | 3856 | Q9UPN3 | |
| GLSSNLKATLLVSYN | 116 | Q86SP6 | |
| ENSYSKGSCLLLGSR | 116 | Q13349 | |
| DLYLNASSFLALING | 186 | Q9UMR5 | |
| SSEKDRANLLLLGYA | 256 | O95876 | |
| SQIKSAGSALYASRL | 246 | Q96IJ6 | |
| ESDILKNYLATRGLT | 556 | Q96EP1 | |
| LDSLSRSNLDKLYHG | 401 | O75419 | |
| GKYESNATALRLALQ | 436 | P23508 | |
| KNTSRLELRSYSLAG | 21 | Q9BZJ0 | |
| LFSNGTLYIRNLASS | 1896 | Q6WRI0 | |
| KLSSLQEGSYLLSHA | 851 | Q659A1 | |
| LFNDVLLYTSRGLTA | 781 | Q9Y4F1 | |
| LLYTSRGLTASNQFK | 786 | Q9Y4F1 | |
| TTSLNQAALYRLSGD | 496 | P51659 | |
| ISDLSSDLYSLGLVS | 781 | O15063 | |
| KTSASLSLDYLLQGT | 1776 | Q9BZC7 | |
| YLTNDIGSSSLTNLK | 2036 | Q12955 | |
| GLTSSIDYSRLNKEL | 141 | Q5TB80 | |
| LNFRVLDSSYGITKS | 176 | Q68D51 | |
| STLLLNNEGSLLAYS | 21 | Q9Y2Q5 | |
| RLLSGSSSDCLYLQS | 491 | Q9NYC9 | |
| TGSLASLEQYSEQLK | 101 | Q7Z3D6 | |
| TLALKSDYISLLASG | 41 | P48509 | |
| QILASGSRDYTLKLF | 186 | Q05048 | |
| TGSLLSYENTDLSLT | 1966 | Q9C0D2 | |
| TAILYLRDQGALDSS | 556 | Q14147 | |
| STLLLNGYQTLEDFK | 271 | O75995 | |
| GEDLYNSSLKNLSTL | 1296 | Q8TDX9 | |
| TSGDSFYIRLNLNIS | 771 | Q9BXL7 | |
| NYLLDNLSGTAKRIT | 151 | Q9ULM6 | |
| ETSARLRGLKSNLAY | 861 | Q9P232 | |
| LSSSLGDAQDEKRYL | 501 | Q6P995 | |
| SLNLNSAYKLLSADG | 341 | Q9UK39 | |
| SAALLAQLKSFYDAR | 46 | Q86V97 | |
| GLDLRNLASDDSYIT | 626 | Q3KNS1 | |
| YKRNETGLSVAASSL | 496 | Q05469 | |
| YKRLLDGFSSSTEQL | 1656 | Q5THK1 | |
| SGLSLNYSDAESLEL | 146 | Q16621 | |
| TAKSRFYGNSLSALL | 501 | Q9H0X9 | |
| LSALSAGSNEYLRSI | 951 | Q99683 | |
| TLSSEGSLNLEDILY | 46 | Q9H7C4 | |
| SYNALTALDSSLRLL | 171 | Q8N1F8 | |
| ALLSSLLGLSNGYLS | 416 | Q9BZD2 | |
| AGSSSLDNLLSRYIS | 691 | Q9UPN9 | |
| SEDTILAQTLGLAYS | 381 | Q15031 | |
| RNSKLTYLLQDSLSG | 721 | Q9BVG8 | |
| TYLLQDSLSGDSKTL | 726 | Q9BVG8 | |
| NLSSTGSRYLNALVD | 86 | Q96CS2 | |
| LAAAYSSILSSLGEN | 71 | P30793 | |
| TYATDLKTDQGLLSN | 426 | Q8TBK2 | |
| EGLSAALASLRNLYT | 896 | Q9C0D5 | |
| SNSLLYTGDLEALQR | 781 | Q8IXF0 | |
| NDYSLSELLSQLDSG | 376 | P57078 | |
| KEFSDALGYLQLLNS | 831 | P36956 | |
| EALLKYRQSTLNSGL | 141 | Q14865 | |
| ISYLASSRQSLLLGD | 306 | Q6ZVT6 | |
| RQLASEITSKGASLY | 141 | Q96AJ1 | |
| SVNLSLLTADLYSLF | 311 | Q5T1Q4 | |
| YSSELNVNALLLGDS | 91 | A0A597 | |
| YDLSNKAASSALGRL | 431 | Q32MQ0 | |
| ANTLLYTSQLSGVKD | 276 | Q5W0Q7 | |
| TGLINLKYLSLSNSF | 376 | O15455 | |
| LLYGDSVDSLRESSN | 1501 | Q8N2C7 | |
| GLSLINSGKRSTADY | 276 | P17040 | |
| LSSLRELYKDANLGS | 296 | Q8IVF5 | |
| LDGLSSNVSDQYLTR | 521 | Q96T58 | |
| EALQSQASSGYASLL | 801 | O15027 | |
| ISEGNSYLLSENLSR | 161 | Q86VV4 | |
| SKSLENFFLRSGSEL | 46 | Q6ZMT1 | |
| SILLNGETREAALSY | 646 | O95155 | |
| KRFYSRGLNSLESTL | 221 | Q8NCL8 | |
| QGRLTSFISLLDKAY | 381 | Q8WWQ8 | |
| LGTYRVADLQTLSSS | 1066 | Q8WWQ8 | |
| FIGLSSVRLLSLYDN | 626 | O94813 | |
| SRTASLVSGLLNELY | 76 | Q9Y2I9 | |
| YSSELNVNALLLGDS | 91 | A0A0A0MS05 | |
| RDYALNTDSAAGLLI | 746 | Q86X10 | |
| TYLTGDQLLSQSKVD | 316 | Q4KWH8 | |
| YSSELNVNALLLGDS | 91 | A0A599 | |
| SSYFLRESLNLLGKL | 146 | Q0D2K0 | |
| QDLVSYLEGSTASLR | 101 | P58753 | |
| ALNLFKTTSGDERLY | 746 | Q7Z3V4 | |
| NDLAAKTVSYSSLGR | 1071 | Q96AY4 | |
| SGSNSLDLKHVTYLR | 391 | P59923 | |
| LGLTYSLQATDASLR | 476 | Q86TV6 | |
| LERGSSSYSQLLAAT | 51 | Q9UIA9 | |
| SKTLQLLNDLSIGYS | 611 | Q9UIA9 | |
| RAILESLFSQYSGKT | 1006 | O43149 | |
| LALGLTYSLQATDAT | 491 | Q9ULT0 | |
| QGSLSSAKNYSELIL | 1056 | Q13395 | |
| ATLSTDLQQGYALKS | 4226 | Q5T4S7 | |
| LNASLDKSSGRSTLY | 81 | A0A0B4J279 | |
| LQLDSGNYLFSTSAI | 51 | P56192 | |
| SQLAKFLLDRYTSSG | 51 | Q9BU19 | |
| GNLQELSARYLSSSA | 301 | Q5SQQ9 | |
| LYSSLNRFGNLTDLN | 71 | Q5R3F8 | |
| LQYSAETLNKSGRLF | 26 | Q6NSI3 | |
| AYIGLKETNRSSALD | 1311 | Q9Y4I1 |